Conformis Awaits “Game Changer” ASC Knee After Dismal 2020

Conformis logo

Conformis reported 4Q20 orthopedic revenue of USD $16.7 million, -16% vs. 4Q19 with full-year 2020 revenue of $68.8 million, -11.2% vs. 2019. Product revenue for 2020 declined -23.6%, while royalty revenues were spared a similar decline due to a $9.6 million settlement with Zimmer Biomet regarding patient specific instruments.

In addition...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us